查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腫瘤市場——按癌症診斷和治療、按癌症類型、按最終用戶和預測，2023-2032 年
市場調查報告書
商品編碼
1262694

腫瘤市場——按癌症診斷和治療、按癌症類型、按最終用戶和預測，2023-2032 年

Oncology Market - By Cancer Diagnostics & Treatment, By Cancer Type, By End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 276 Pages | 商品交期: 2-3個工作天內

價格

在全球癌症發病率上升的背景下，腫瘤學市場預計將從 2023 年到 2032 年經歷顯著增長。

根據世界衛生組織的統計，癌症是全球主要死因之一，預計到 2020 年將有大約 1000 萬人死亡。 出於這個原因，需要廣泛的治療選擇來治療這種疾病。 化療、手術和放療等各種治療方法被用於癌症治療，因為它們在癌症治療中不僅具有治愈作用，而且具有姑息作用。

新興經濟體的研究人員、政府官員和市場參與者的技術創新將進一步影響到 2032 年的行業增長。 例如，英國政府技術轉讓署 (GOTT) 已資助國家物理實驗室開發新的超聲技術以增強乳腺癌診斷。

腫瘤學行業分為癌症診斷和治療、癌症、最終用途和地理。

基於癌症診斷和治療，癌症診斷領域有望隨著時間的推移提供有益的回報。 推動這一領域增長的基本因素包括癌症發病率的增加和該領域的技術進步。 也有人說，僅靠體格檢查和生物標誌物檢測來檢測癌症是一項繁瑣的工作，而影像學檢查對於確診癌症是必不可少的。 這種趨勢正在推動對高級診斷成像的需求並推動市場增長。

至於癌症，肥胖、荷爾蒙失調和與衰老相關的風險增加導致乳腺癌發病率迅速增加，預計未來十年乳腺癌細分市場份額將大幅增長。 Cancer.net 的統計數據預測，到 2023 年，美國將有超過 43,500 人死於乳腺癌。 此外，新西蘭和其他地方的 BreastScreen Aotearoa 等各種政府舉措將通過為女性提供免費檢測來進一步擴大市場規模。

近年來，腫瘤治療通常在專科診所進行。 這些醫療保健設施充當某些類型癌症治療的先進癌症治療設施。 在這些醫療機構進行癌症檢測和篩查的先進技術和專業腫瘤學家的可用性進一步推動了業務的增長。

此外，不用說，用於篩查和診斷的先進技術的可用性將為患者提供有吸引力的癌症治療機會。

從地理上講，亞太地區可能會成為腫瘤學行業的熱點。 根據該報告，預計 2023 年至 2032 年亞太地區腫瘤市場的複合年增長率將超過 11.5%。 該地區的增長可能是由於印度、日本和中國等國家的癌症病例激增。 順便說一下，癌症登記數據顯示，印度每年大約有 80 萬例新癌症病例。

此外，亞太地區主要製藥公司新開發的抗癌藥物在當地人群中的意識不斷增強，預計也將推動未來幾年的市場增長。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章腫瘤行業洞察

  • 按行業細分
  • 2018-2032 年行業形勢變化
  • 影響行業的因素
    • 司機
      • 全球癌症發病率上升
      • 政府和其他組織為傳播疾病意識所做的多項努力
      • 發展中國家的診斷中心數量不斷增加
      • 發達國家的技術進步
    • 行業潛在的風險和挑戰
      • 診斷成像系統的高資本投資和高成本
      • 與癌症治療相關的副作用和與 CT 掃描儀相關的風險也很高
      • 缺乏訓練有素的腫瘤科醫生和放射科醫生
  • 增長分析
    • 癌症診斷/治療藥物
    • 按癌症類型
    • 按最終用途
  • COVID-19 影響分析
  • 2021 年腫瘤學臨床試驗量分析
    • 2017-2021 年按地區劃分的腫瘤臨床試驗量
    • 2017-2021 年腫瘤臨床試驗量，癌症類型
    • 2017-2021 年按發展階段劃分的腫瘤學臨床試驗量
  • 管道解析
  • 波特分析
  • PESTEL 分析

第 4 章競爭格局，2021 年

  • 介紹
  • 公司矩陣分析
  • 2021 年各公司的頂級抗癌藥物產品
  • 主要市場參與者的競爭分析
    • F. Hoffmann-La Roche
    • Janssen Diagnostics，LCC
    • 輝瑞公司
    • 通用電氣醫療
  • 2021 年腫瘤製藥公司股票分析
  • 戰略儀表板

第 5 章腫瘤市場：癌症診斷和治療

  • 癌症診斷和治療的主要趨勢
  • 癌症診斷劑
    • 腫瘤生物標誌物測試
    • 成像
    • 活檢
    • 液體活檢
    • 免疫組織化學
    • 原位雜交
  • 癌症治療
    • 免疫組織化學
    • 靶向治療
    • 免疫療法
    • 激素療法
    • 其他

第 6 章腫瘤學市場：按癌症類型分類

  • 主要癌症類型的趨勢
  • 肺癌
  • 前列腺癌
  • 結腸癌和直腸癌
  • 胃癌
  • 食管癌
  • 肝癌
  • 乳腺癌
  • 其他

第 7 章腫瘤學市場：按最終用戶分類

  • 主要的最終用戶趨勢
  • 醫院
  • 診斷實驗室
  • 影像診斷中心
  • 學術界
  • 專科門診
  • 其他

第 8 章腫瘤學市場：按區域分類

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 波蘭
    • 瑞士
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 印度尼西亞
    • 泰國
    • 越南
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列

第九章公司簡介

  • Abbott
  • Bayer AG
  • Biocartis
  • BioMerieux SA
  • Bio-Rad Laboratories
  • GE Healthcare
  • Astellas Pharma, Inc.
  • AstraZeneca
  • Janssen Diagnostic LLC（Johnson & Johnson）
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Thermo Fischer Scientific
  • Siemens Healthineers
  • Kite Pharma（Gilead Sciences Inc）
  • Amgen
  • AstraZeneca
  • Merck & Co.
  • Abbive Inc.
  • Pfizer
Product Code: 4879

Oncology Market is expected to garner commendable gains over 2023 to 2032, fueled by the growing cancer prevalence worldwide. As per WHO statistics, cancer is one of the leading causes of fatalities worldwide, resulting in nearly 10 million deaths in 2020. This calls for broad treatment options to treat the disease. Various therapies such as chemotherapy, surgery, and radiation therapy are employed in cancer therapy subject to the pivotal benefits in terms of providing palliative as well as curative effect in cancer treatment.

Technological innovations by researchers, government officials, and market players in developed economies would further influence the industry growth through 2032. For instance, the Government Office for Technology Transfer (GOTT), UK, funded the National Physical Laboratory's novel development of ultrasound technology to enhance breast cancer diagnosis.

The oncology industry is segmented into cancer diagnostics and treatment, cancer, end-use, and region.

Based on cancer diagnostics and treatment, the cancer diagnostics segment is slated to churn profitable returns over the due course of time. Fundamental factors driving the segmental growth include growing incidences of cancer and technological advancements in the space. In addition, detecting cancer with only physical exams or biomarker tests is noted to be a monotonous task while imaging test is essential for conformation. These trends thus prompt the demand for advanced imaging modalities, stimulating the market growth.

Considering the cancer, oncology market share from breast cancer segment would accrue massive gains over the next ten years, owing to the alarming breast cancer incidences due to rising obesity, hormonal imbalance cases, and age-related risks. As per Cancer.net statistics, it has been projected that breast cancer could lead to more than 43,500 deaths in the United States in 2023. Besides, various government efforts such as BreastScreen Aotearoa in New Zealand and other countries, providing free tests to women would further boost the market size.

Oncology treatment is being largely accommodated in specialty clinics over the recent years. These healthcare settings stand as advanced cancer care establishments that cater to specific types of cancer treatments. Increased availability of advanced technology for detection and screening and specialist oncologists across these settings would further encourage the business growth.

Not to mention, growing availability of advanced technology for screening and diagnosis would offer attractive opportunities to patients for cancer treatment.

Regionally, Asia Pacific is likely to emerge as a regional hotspot for oncology industry. As per reports, the APAC oncology market is predicted to grow at more than 11.5% CAGR between 2023 to 2032. The regional growth can be credited to the burgeoning cases of cancer in countries such as India, Japan, and China. For the record, a cancer registry data reveals that there would be approximately 800,000 new cancer cases in India every year.

Furthermore, growing cognizance among the regional population about the newly developed cancer medications by key pharmaceutical companies in the Asia Pacific would foster the regional market growth in the years ahead.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope and definitions
  • 1.3 Base estimates and working
  • 1.4 Forecast parameters
  • 1.5 COVID-19 impact analysis at global level
  • 1.6 Data validation
  • 1.7 Data sources
    • 1.7.1 Primary
    • 1.7.2 Secondary
      • 1.7.2.1 Paid sources
      • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Oncology industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Cancer diagnostic & treatment trends
    • 2.1.3 Cancer type trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Oncology Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising incidence of cancer globally
      • 3.3.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
      • 3.3.1.3 Growing number of diagnostic laboratories in developing countries
      • 3.3.1.4 Technological advancements in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High capital investment coupled with high cost associated with diagnostic imaging system
      • 3.3.2.2 High risk of side effects associated with cancer treatment and risks associated with CT scanners
      • 3.3.2.3 Dearth of well-skilled and trained oncologists and radiologists
  • 3.4 Growth potential analysis
    • 3.4.1 By cancer diagnostics & treatment
    • 3.4.2 By cancer type
    • 3.4.3 By end-use
  • 3.5 COVID- 19 impact analysis
  • 3.6 Oncology clinical trial volume analysis, 2021
    • 3.6.1 Oncology clincial trial volume, by region, 2017 - 2021
    • 3.6.2 Oncology clinical trial volume, by cancer type, 2017 - 2021
    • 3.6.3 Oncology clinical trial volume, by phase of development, 2017 - 2021
  • 3.7 Pipeline analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Top oncology drugs, by company, 2021
  • 4.4 Competitive analysis of major market players
    • 4.4.1 F. Hoffmann-La Roche
    • 4.4.2 Janssen Diagnostics, LCC
    • 4.4.3 Pfizer, Inc
    • 4.4.4 GE Healthcare
  • 4.5 Oncology drugs company market share analysis, 2021
  • 4.6 Strategic dashboard

Chapter 5 Oncology Market, By Cancer Diagnostics & Treatment

  • 5.1 Key cancer diagnostics & treatment trends
  • 5.2 Cancer diagnostics
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.2 Tumor biomarkers tests
      • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.3 Imaging
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Biopsy
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.5 Liquid biopsy
      • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.6 Immunohistochemistry
      • 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.7 In situ hybridization
      • 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Cancer treatment
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Immunohistochemistry
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Targeted therapy
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Immunotherapy
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Hormonal therapy
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.6 Others
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Oncology Market, By Cancer Type

  • 6.1 Key cancer type trends
  • 6.2 Lung cancer
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Prostate cancer
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Colon & rectal cancer
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Gastric cancer
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.6 Esophageal cancer
    • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.7 Liver cancer
    • 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.8 Breast cancer
    • 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.9 Others
    • 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Oncology Market, By End-use

  • 7.1 Key end-use trends
  • 7.2 Hospitals
    • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.3 Diagnostic laboratories
    • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.4 Diagnostic imaging centers
    • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.5 Academia
    • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.6 Specialty clinics
    • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 7.7 Others
    • 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Oncology Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Poland
    • 8.3.7 Switzerland
    • 8.3.8 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Indonesia
    • 8.4.7 Thailand
    • 8.4.8 Vietnam
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Columbia
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Abbott
  • 9.2 Bayer AG
  • 9.3 Biocartis
  • 9.4 BioMerieux SA
  • 9.5 Bio-Rad Laboratories
  • 9.6 GE Healthcare
  • 9.7 Astellas Pharma, Inc.
  • 9.8 AstraZeneca
  • 9.9 Janssen Diagnostic LLC (Johnson & Johnson)
  • 9.10 F. Hoffmann-La Roche Ltd
  • 9.11 Sysmex Corporation
  • 9.12 Thermo Fischer Scientific
  • 9.13 Siemens Healthineers
  • 9.14 Kite Pharma (Gilead Sciences Inc)
  • 9.15 Amgen
  • 9.16 AstraZeneca
  • 9.17 Merck & Co.
  • 9.18 Abbive Inc.
  • 9.19 Pfizer

Data Tables

  • TABLE 1. Market revenue, by cancer diagnostics & treatment (2022)
  • TABLE 2. Market revenue, by cancer type (2022)
  • TABLE 3. Market revenue, by end-use (2022)
  • TABLE 4. Market share, by region (2022)
  • TABLE 5. Global oncology market, 2018-2022 (USD Million)
  • TABLE 6. Global oncology market, 2023-2032 (USD Million)
  • TABLE 7. Global oncology market, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 8. Global oncology market, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 9. Global oncology market, by cancer type, 2018-2022 (USD Million)
  • TABLE 10. Global oncology market, by cancer type, 2023-2032 (USD Million)
  • TABLE 11. Global oncology market, by end-use, 2018-2022 (USD Million)
  • TABLE 12. Global oncology market, by end-use, 2023-2032 (USD Million)
  • TABLE 13. Global oncology market, by region, 2018-2022 (USD Million)
  • TABLE 14. Global oncology market, by region, 2023-2032 (USD Million)
  • TABLE 15. Industry impact forces
  • TABLE 16. Cancer diagnostics market size, 2018-2022 (USD Million)
  • TABLE 17. Cancer diagnostics market size, 2023-2032 (USD Million)
  • TABLE 18. Tumor biomarkers tests market size, 2018-2022 (USD Million)
  • TABLE 19. Tumor biomarkers tests market size, 2023-2032 (USD Million)
  • TABLE 20. Imaging market size, 2018-2022 (USD Million)
  • TABLE 21. Imaging market size, 2023-2032 (USD Million)
  • TABLE 22. Biopsy market size, 2018-2022 (USD Million)
  • TABLE 23. Biopsy market size, 2023-2032 (USD Million)
  • TABLE 24. Liquid biopsy market size, 2018-2022 (USD Million)
  • TABLE 25. Liquid biopsy market size, 2023-2032 (USD Million)
  • TABLE 26. Immunohistochemistry market size, 2018-2022 (USD Million)
  • TABLE 27. Immunohistochemistry market size, 2023-2032 (USD Million)
  • TABLE 28. In situ hybridization market size, 2018-2022 (USD Million)
  • TABLE 29. In situ hybridization market size, 2023-2032 (USD Million)
  • TABLE 30. Cancer treatment market size, 2018-2022 (USD Million)
  • TABLE 31. Cancer treatment market size, 2023-2032 (USD Million)
  • TABLE 32. Chemotherapy market size, 2018-2022 (USD Million)
  • TABLE 33. Chemotherapy market size, 2023-2032 (USD Million)
  • TABLE 34. Targeted therapy market size, 2018-2022 (USD Million)
  • TABLE 35. Targeted therapy market size, 2023-2032 (USD Million)
  • TABLE 36. Immunotherapy market size, 2018-2022 (USD Million)
  • TABLE 37. Immunotherapy market size, 2023-2032 (USD Million)
  • TABLE 38. Hormonal therapy market size, 2018-2022 (USD Million)
  • TABLE 39. Hormonal therapy market size, 2023-2032 (USD Million)
  • TABLE 40. Others market size, 2018-2022 (USD Million)
  • TABLE 41. Others market size, 2023-2032 (USD Million)
  • TABLE 42. Lung cancer market size, 2018-2022 (USD Million)
  • TABLE 43. Lung cancer market size, 2023-2032 (USD Million)
  • TABLE 44. Prostate cancer market size, 2018-2022 (USD Million)
  • TABLE 45. Prostate cancer market size, 2023-2032 (USD Million)
  • TABLE 46. Colon and rectal cancer market size, 2018-2022 (USD Million)
  • TABLE 47. Colon and rectal cancer market size, 2023-2032 (USD Million)
  • TABLE 48. Gastric cancer market size, 2018-2022 (USD Million)
  • TABLE 49. Gastric cancer market size, 2023-2032 (USD Million)
  • TABLE 50. Esophageal cancer market size, 2018-2022 (USD Million)
  • TABLE 51. Esophageal cancer market size, 2023-2032 (USD Million)
  • TABLE 52. Liver market size, 2018-2022 (USD Million)
  • TABLE 53. Liver market size, 2023-2032 (USD Million)
  • TABLE 54. Breast cancer market size, 2018-2022 (USD Million)
  • TABLE 55. Breast cancer market size, 2023-2032 (USD Million)
  • TABLE 56. Others market size, 2018-2022 (USD Million)
  • TABLE 57. Others market size, 2023-2032 (USD Million)
  • TABLE 58. Hospitals market size, 2018-2022 (USD Million)
  • TABLE 59. Hospitals market size, 2023-2032 (USD Million)
  • TABLE 60. Diagnostic laboratories market size, 2018-2022 (USD Million)
  • TABLE 61. Diagnostic laboratories market size, 2023-2032 (USD Million)
  • TABLE 62. Diagnostic imaging centers market size, 2018-2022 (USD Million)
  • TABLE 63. Diagnostic imaging centers market size, 2023-2032 (USD Million)
  • TABLE 64. Academia market size, 2018-2022 (USD Million)
  • TABLE 65. Academia market size, 2023-2032 (USD Million)
  • TABLE 66. Specialty clinics market size, 2018-2022 (USD Million)
  • TABLE 67. Specialty clinics market size, 2023-2032 (USD Million)
  • TABLE 68. Others market size, 2018-2022 (USD Million)
  • TABLE 69. Others market size, 2023-2032 (USD Million)
  • TABLE 70. North America oncology market size, by country, 2018-2022 (USD Million)
  • TABLE 71. North America oncology market size, by country, 2023-2032 (USD Million)
  • TABLE 72. North America oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 73. North America oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 74. North America oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 75. North America oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 76. North America oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 77. North America oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 78. North America oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 79. North America oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 80. North America oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 81. North America oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 82. U.S. oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 83. U.S. oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 84. U.S. oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 85. U.S. oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 86. U.S. oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 87. U.S. oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 88. U.S. oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 89. U.S. oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 90. U.S. oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 91. U.S. oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 92. Canada oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 93. Canada oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 94. Canada oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 95. Canada oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 96. Canada oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 97. Canada oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 98. Canada oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 99. Canada oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 100. Canada oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 101. Canada oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 102. Europe oncology market size, by country, 2018-2022 (USD Million)
  • TABLE 103. Europe oncology market size, by country, 2023-2032 (USD Million)
  • TABLE 104. Europe oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 105. Europe oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 106. Europe oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 107. Europe oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 108. Europe oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 109. Europe oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 110. Europe oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 111. Europe oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 112. Europe oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 113. Europe oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 114. Germany oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 115. Germany oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 116. Germany oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 117. Germany oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 118. Germany oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 119. Germany oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 120. Germany oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 121. Germany oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 122. Germany oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 123. Germany oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 124. UK oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 125. UK oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 126. UK oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 127. UK oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 128. UK oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 129. UK oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 130. UK oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 131. UK oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 132. UK oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 133. UK oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 134. France oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 135. France oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 136. France oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 137. France oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 138. France oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 139. France oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 140. France oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 141. France oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 142. France oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 143. France oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 144. Spain oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 145. Spain oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 146. Spain oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 147. Spain oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 148. Spain oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 149. Spain oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 150. Spain oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 151. Spain oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 152. Spain oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 153. Spain oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 154. Italy oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 155. Italy oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 156. Italy oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 157. Italy oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 158. Italy oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 159. Italy oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 160. Italy oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 161. Italy oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 162. Italy oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 163. Italy oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 164. Poland oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 165. Poland oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 166. Poland oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 167. Poland oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 168. Poland oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 169. Poland oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 170. Poland oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 171. Poland oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 172. Poland oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 173. Poland oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 174. Switzerland oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 175. Switzerland oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 176. Switzerland oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 177. Switzerland oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 178. Switzerland oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 179. Switzerland oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 180. Switzerland oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 181. Switzerland oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 182. Switzerland oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 183. Switzerland oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 184. Netherlands oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 185. Netherlands oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 186. Netherlands oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 187. Netherlands oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 188. Netherlands oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 189. Netherlands oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 190. Netherlands oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 191. Netherlands oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 192. Netherlands oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 193. Netherlands oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 194. Asia Pacific oncology market size, by country, 2018-2022 (USD Million)
  • TABLE 195. Europe oncology market size, by country, 2023-2032 (USD Million)
  • TABLE 196. Asia Pacific oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 197. Asia Pacific oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 198. Asia Pacific oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 199. Asia Pacific oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 200. Asia Pacific oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 201. Asia Pacific oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 202. Asia Pacific oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 203. Asia Pacific oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 204. Asia Pacific oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 205. Asia Pacific oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 206. China oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 207. China oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 208. China oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 209. China oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 210. China oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 211. China oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 212. China oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 213. China oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 214. China oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 215. China market size, by end-use, 2023-2032 (USD Million)
  • TABLE 216. India oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 217. India oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 218. India oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 219. India oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 220. India oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 221. India oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 222. India oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 223. India oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 224. India oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 225. India oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 226. Japan oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 227. Japan oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 228. Japan oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 229. Japan oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 230. Japan oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 231. Japan oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 232. Japan oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 233. Japan oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 234. Japan oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 235. Japan oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 236. Australia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 237. Australia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 238. Australia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 239. Australia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 240. Australia oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 241. Australia oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 242. Australia oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 243. Australia oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 244. Australia oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 245. Australia oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 246. South Korea oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 247. South Korea oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 248. South Korea oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 249. South Korea oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 250. South Korea oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 251. South Korea oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 252. South Korea oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 253. South Korea oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 254. South Korea oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 255. South Korea oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 256. Indonesia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 257. Indonesia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 258. Indonesia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 259. Indonesia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 260. Indonesia oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 261. Indonesia oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 262. Indonesia oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 263. Indonesia oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 264. Indonesia oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 265. Indonesia oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 266. Thailand oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 267. Thailand oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 268. Thailand oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 269. Thailand oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 270. Thailand oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 271. Thailand oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 272. Thailand oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 273. Thailand oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 274. Thailand oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 275. Thailand oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 276. Vietnam oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 277. Vietnam oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 278. Vietnam oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 279. Vietnam oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 280. Vietnam oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 281. Vietnam oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 282. Vietnam oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 283. Vietnam oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 284. Vietnam oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 285. Vietnam oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 286. Latin America oncology market size, by country, 2018-2022 (USD Million)
  • TABLE 287. Latin America oncology market size, by country, 2023-2032 (USD Million)
  • TABLE 288. Latin America oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 289. Latin America oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 290. Latin America oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 291. Latin America oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 292. Latin America oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 293. Latin America oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 294. Latin America oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 295. Latin America oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 296. Latin America oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 297. Latin America oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 298. Brazil oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 299. Brazil oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 300. Brazil oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 301. Brazil oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 302. Brazil oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 303. Brazil oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 304. Brazil oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 305. Brazil oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 306. Brazil oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 307. Brazil market size, by end-use, 2023-2032 (USD Million)
  • TABLE 308. Mexico oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 309. Mexico oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 310. Mexico oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 311. Mexico oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 312. Mexico oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 313. Mexico oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 314. Mexico oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 315. Mexico oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 316. Mexico oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 317. Mexico oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 318. Argentina oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 319. Argentina oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 320. Argentina oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 321. Argentina oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 322. Argentina oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 323. Argentina oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 324. Argentina oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 325. Argentina oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 326. Argentina oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 327. Argentina oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 328. Columbia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 329. Columbia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 330. Columbia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 331. Columbia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 332. Columbia oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 333. Columbia oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 334. Columbia oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 335. Columbia oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 336. Columbia oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 337. Columbia oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 338. MEA oncology market size, by country, 2018-2022 (USD Million)
  • TABLE 339. MEA oncology market size, by country, 2023-2032 (USD Million)
  • TABLE 340. MEA oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 341. MEA oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 342. MEA oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 343. MEA oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 344. MEA oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 345. MEA oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 346. MEA oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 347. MEA oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 348. MEA oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 349. MEA oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 350. South Africa oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 351. South Africa oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 352. South Africa oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 353. South Africa oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 354. South Africa oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 355. South Africa oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 356. South Africa oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 357. South Africa oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 358. South Africa oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 359. South Africa market size, by end-use, 2023-2032 (USD Million)
  • TABLE 360. Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 361. Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 362. Saudi Arabia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 363. Saudi Arabia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 364. Saudi Arabia oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 365. Saudi Arabia oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 366. Saudi Arabia oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 367. Saudi Arabia oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 368. Saudi Arabia oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 369. Saudi Arabia oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 370. UAE oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 371. UAE oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 372. UAE oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 373. UAE oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 374. UAE oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 375. UAE oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 376. UAE oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 377. UAE oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 378. UAE oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 379. UAE oncology market size, by end-use, 2023-2032 (USD Million)
  • TABLE 380. Israel oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
  • TABLE 381. Israel oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
  • TABLE 382. Israel oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
  • TABLE 383. Israel oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
  • TABLE 384. Israel oncology market size, by cancer treatment, 2018-2022 (USD Million)
  • TABLE 385. Israel oncology market size, by cancer treatment, 2023-2032 (USD Million)
  • TABLE 386. Israel oncology market size, by cancer type, 2018-2022 (USD Million)
  • TABLE 387. Israel oncology market size, by cancer type, 2023-2032 (USD Million)
  • TABLE 388. Israel oncology market size, by end-use, 2018-2022 (USD Million)
  • TABLE 389. Israel oncology market size, by end-use, 2023-2032 (USD Million)

Charts & Figures

  • Fig.1 GMI report coverage: critical research elements
  • Fig.2 Industry segmentation
  • Fig.3 Top-down approach
  • Fig.4 Market forecasting methodology
  • Fig.5 Profile break-up of primary respondents
  • Fig.6 Oncology industry 360 degree synopsis, 2018 - 2032
  • Fig.7 Global oncology market size, 2018 - 2032, (USD Million)
  • Fig.8 Growth potential analysis, by cancer treatment & diagnostics
  • Fig.9 Growth potential analysis, by cancer type
  • Fig.10 Growth potential analysis, by end-use
  • Fig.11 Porter's analysis
  • Fig.12 PESTEL analysis
  • Fig.13 Company matrix analysis
  • Fig.14 Competitive analysis of major market players
  • Fig.15 Oncology drugs company market share analysis, 2021
  • Fig.16 Strategy dashboard